Director General of the world health organization (who), Tedros of Ghebreyesus responded to the results of clinical trials of steroid drug dexamethasone in the treatment of coronavirus infection in the UK. He called them “scientific breakthrough”.
He noted that this is the first drug that showed a decrease in mortality among patients with COVID-19 who require mechanical ventilation and oxygen support.
According to preliminary data, the use of dexamethasone showed a decrease in mortality among patients on mechanical ventilation by one-third, and among patients who are on oxygen support for 20%.
Earlier, the who changed the recommendation about wearing masks.